Merck Dulera shows efficacy in COPD treatment – Pharmaceutical Business Review

Merck Dulera shows efficacy in COPD treatment
Pharmaceutical Business Review
Dulera Inhalation Aerosol, which is used to treat asthma combines mometasone furoate, an inhaled corticosteroid, and formoterol fumarate, a long-acting beta2-agonist. The two 26-week, multicenter, double-blind, placebo controlled trials comprising 2251
Merck Announces Presentation of Phase III Investigational Studies Evaluating MarketWatch (press release)

all 12 news articles »

View full post on asthma – Google News

Studies Ordered for Side Effects of Symbicort, Advair Diskus, Dulera, Foradil – AboutLawsuits.com

Studies Ordered for Side Effects of Symbicort, Advair Diskus, Dulera, Foradil
AboutLawsuits.com
Federal drug regulators have ordered that new studies be done to examine potential safety problems with a number of asthma drugs, including Advair, Symbicort, Dulera and Foradil. The FDA announced it was requiring the new clinical safety trials on
Already Available Asthma Medications FDA Orders Trialsallvoices

all 4 news articles »

View full post on asthma – Google News